Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Regeneron (REGN) , which belongs to the Zacks Medical - Biomedical and Genetics industry. This biopharmaceutical company has an established record of topping earnings estimates, especially when looking at the previous two reports. The company boasts an average surprise for the past two quarters of 10.51%. For the most recent quarter, Regeneron was expected to ...